Among companies trading on the New York Stock Exchange and the Nasdaq, health care companies trade significantly below their median price-sales (P/S) valuation. At least five companies made the “Undervalued Biotech” screener, including Biogen Inc. (NASDAQ:BIIB), Gilead Sciences Inc. (NASDAQ:GILD), JAZZ Pharmaceuticals PLC (NASDAQ:JAZZ), Novo Nordisk A/S (NYSE:NVO) and United Therapeutics Corp. (NASDAQ:UTHR). As these companies present strong value potential to investors and shareholders, several gurus have invested in these companies.
This article is Part 3 in a series of articles discussing how to visualize financial trends with interactive charts. In Part 1, we introduced interactive charts and explored preliminary features within the interface. We then explored a few predefined interactive charts in Part 2, including the income statement chart and the balance sheet chart. Continue Reading »